Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival

被引：0
|
作者：
Chen, James X. [1 ]
Rose, Steven [2 ]
White, Sarah B. [3 ]
El-Haddad, Ghassan [4 ]
Fidelman, Nicholas [5 ]
Yarmohammadi, Hooman [6 ]
Sze, Daniel [7 ]
Salem, Riad [8 ]
Metz, David [9 ]
Soulen, Michael C. [1 ]
机构：
[1] Hosp Univ Penn, Div Intervent Radiol, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ San Diego, Med Ctr, Div Intervent Radiol, Dept Radiol, San Diego, CA 92110 USA
[3] Univ Wisconsin, Sch Med, Div Intervent Radiol, Dept Radiol, Madison, WI USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Div Intervent Radiol, Dept Radiol, Tampa, FL USA
[5] Univ San Francisco, Med Ctr, Div Intervent Radiol, Dept Radiol, San Francisco, CA 94117 USA
[6] Mem Sloan Kettering Canc Ctr, Div Intervent Radiol, Dept Radiol, 1275 York Ave, New York, NY 10021 USA
[7] Stanford Univ, Med Ctr, Div Intervent Radiol, Dept Radiol, Stanford, CA 94305 USA
[8] NW Mem Hosp, Div Intervent Radiol, Dept Radiol, Chicago, IL 60611 USA
[9] Hosp Univ Penn, Div Gastroenterol, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
PANCREAS | 2016年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [21] Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival
    S. H. Bakker
    W. C. H. Jacobs
    W. Pondaag
    H. Gelderblom
    R. A. Nout
    P. D. S. Dijkstra
    W. C. Peul
    C. L. A. Vleggeert-Lankamp
    European Spine Journal, 2018, 27 : 3043 - 3058
  • [22] Soluble MICA as a prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, V.
    Schuett, P.
    Brandhorst, D.
    Opalka, B.
    Nowrousian, M. R.
    Moritz, T.
    Grosse-Wilde, H.
    TISSUE ANTIGENS, 2007, 69 (05): : 390 - 390
  • [23] Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors
    Kanamori, Masayuki
    Kumabe, Toshihiro
    Sonoda, Yukihiko
    Nishino, Yoshikazu
    Watanabe, Mika
    Tominaga, Teiji
    JOURNAL OF NEURO-ONCOLOGY, 2009, 93 (02) : 219 - 228
  • [24] Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors
    Masayuki Kanamori
    Toshihiro Kumabe
    Yukihiko Sonoda
    Yoshikazu Nishino
    Mika Watanabe
    Teiji Tominaga
    Journal of Neuro-Oncology, 2009, 93 : 219 - 228
  • [25] Prolonged progression-free survival achieved by octreotide LAR plus transarterial embolization in low-to-intermediate grade neuroendocrine tumor liver metastases with high hepatic tumor burden
    Liu, Yiming
    Liu, Haikuan
    Chen, Wenchuan
    Yu, Hang
    Yao, Wang
    Fan, Wenzhe
    Li, Jiaping
    Chen, Minhu
    Chen, Jie
    Wang, Yu
    CANCER MEDICINE, 2022, 11 (13): : 2588 - 2600
  • [26] Interstitial Brachytherapy for Hepatocellular Carcinoma: Analysis of Prognostic Factors for Overall Survival and Progression-Free Survival and Application of a Risk Stratification Model
    Thormann, Maximilian
    Heitmann, Franziska
    Wrobel, Vanessa
    Heinze, Constanze
    March, Christine
    Hass, Peter
    Damm, Robert
    Surov, Alexey
    Pech, Maciej
    Omari, Jazan
    DIGESTIVE DISEASES, 2023, 41 (06) : 957 - 966
  • [27] Progression-free survival as a surrogate for overall survival in advanced cancer.
    Gillies, Eric
    Holdai, Veera
    Cowall, David Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] OVERALL SURVIVAL VERSUS PROGRESSION-FREE SURVIVAL IN ONCOLOGY CLINICAL TRIALS
    Aissaoui, A.
    Bin Sawad, A.
    Turkistani, F.
    Aissaoui, N.
    VALUE IN HEALTH, 2016, 19 (07) : A717 - A717
  • [29] Progression-Free Survival as a Surrogate Marker of Overall Survival Is It the Good Question?
    Escudier, Bernard
    CANCER, 2011, 117 (12) : 2586 - 2587
  • [30] Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
    Li, Jiayi
    Cao, Dongyan
    FRONTIERS IN ONCOLOGY, 2022, 12
12345